Three years after convincing two ex-Genentech colleagues to join her on a hunt of a new form of immuno-oncology, Charlene Liao and her startup, Immune-Onc, are in the clinic and armed with a new round of cash to push the lead candidate through.
Immune-Onc announced on Tuesday $73 million…